Team: Therapy Trainers

Home » Our Mission » Who We Are »
Keren Tzarfaty, Ph.D., M.F.T.
Keren Tzarfaty, Ph.D., M.F.T.

Keren Tzarfaty, Ph.D., M.F.T.

Principal Investigator for MDMA-Assisted Therapy Research

Keren Tzarfaty, Ph.D.,M.F.T., is the co-founder of the Hakomi Institute of Israel a trainer for MAPS in Israel (Multidisciplinary Association for Psychedelic Studies). She is a clinical investigator in the MDMA PTSD FDA approved clinical trial, examining the impact of MDMA assisted psychotherapy on severe PTSD patients. Keren is the clinical director of the Open Access project of MAPS and the Israeli MOH, which offers MDMA assisted therapy for 50 participants in five governmental hospitals in Israel. She is also one of the founder of the new MA program in Haifa University: Integrative psychotherapy,: Body, Mind, spirit.  Keren holds a M.A. in Somatic Psychology and a Ph.D. in East- West Psychology, both from the California Institute of Integral Studies in San Francisco. She specializes in integrating mindfulness based psychodynamic psychotherapy with somatic psychotherapy, attachment psychotherapy, trauma psychology and transpersonal psychology. Her approach is grounded in traditional western psychologies as well as inspired by Eastern and Shamanic spiritual traditions.


MAPS Public Benefit Corporation

Our Mission
Who We Are
Contact Us
Privacy Policy

Cookie Policy

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Stay Up-to-Date about the MDMA-AT Education Program

You have Successfully Subscribed!